Ranked #6,628 of 8,699 institutional investors
Superstring Capital Management LP
New York, NY
$175M
US stock portfolio at live prices · today −$18K (−0.01%)
Market closed. Prices as of Nov 20, 6:11 AM ET
- Value at quarter end (Q3 2026)
- $200M
- Change from Q2 2026
- +$41.1M (+25.97%)
- Positions
- 32 · 12 new, 7 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$16.4M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesGMAB 10.7%COGT 9.49%AXSM 7.96%TRVI 7.73%CLYM 4.88%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| GMAB Genmab A/S | 365,662 | $18.8M | 10.7% | Reduced −15% |
| COGT Cogent Biosciences, Inc. | 597,408 | $16.6M | 9.49% | Added +74% |
| AXSM Axsome Therapeutics, Inc. | 102,485 | $13.9M | 7.96% | Added +90% |
| TRVI Trevi Therapeutics, Inc. | 984,892 | $13.5M | 7.73% | Added +88% |
| CLYM Climb Bio Inc | 918,231 | $8.5M | 4.88% | Added +76% |
| ZLAB Zai Lab Limited | 362,671 | $7.9M | 4.55% | Added +133% |
| UTHR United Therapeutics Corporation | 13,321 | $7.4M | 4.26% | Added +86% |
| IMVT Immunovant, Inc. | 222,121 | $7.2M | 4.13% | Added +7% |
| CLDX Celldex Therapeutics, Inc. | 242,493 | $6.8M | 3.88% | Reduced −16% |
| RVMD Revolution Medicines, Inc. | 41,784 | $6.7M | 3.81% | Reduced −18% |
| LEGN Legend Biotech Corporation | 357,359 | $5.8M | 3.29% | New |
| ANL Adlai Nortye Group Ltd. | 588,418 | $5.3M | 3.05% | Added +7% |
| SVRA Savara Inc. | 1,017,817 | $5.3M | 3.04% | Added +4% |
| DFTX Definium Therapeutics, Inc. | 176,561 | $5.2M | 2.98% | Reduced −6% |
| VIR Vir Biotechnology, Inc. | 578,696 | $5.1M | 2.94% | Reduced −32% |
| SGMT Sagimet Biosciences Inc. | 423,006 | $4.1M | 2.33% | New |
| IONS Ionis Pharmaceuticals, Inc. | 132,339 | $3.6M | 2.06% | New |
| SYRE Spyre Therapeutics, Inc. | 30,022 | $2.9M | 1.68% | New |
| ABVX ABIVAX Société Anonyme | 30,020 | $2.4M | 1.39% | New |
| DNA Ginkgo Bioworks Holdings, Inc. | 222,553 | $1.8M | 1.04% | New |
| TSHA Taysha Gene Therapies, Inc. | 413,373 | $1.6M | 0.89% | New |
| ORKA Oruka Therapeutics, Inc. | 15,446 | $1.5M | 0.86% | New |
| LTGO Latigo Biotherapeutics, Inc. | 88,178 | $1.2M | 0.67% | New |
| XENE Xenon Pharmaceuticals Inc. | 26,496 | $995K | 0.57% | New |
| DRUG Bright Minds Biosciences Inc. | 48,045 | $995K | 0.57% | Added +58% |
| MDGL Madrigal Pharmaceuticals, Inc. | 2,099 | $833K | 0.48% | New |
| MPLT MapLight Therapeutics, Inc. | 118,304 | $760K | 0.43% | Reduced −6% |
| CABA Cabaletta Bio, Inc. | 517,412 | $523K | 0.30% | Reduced −60% |
| BOLD Boundless Bio, Inc. | 206,242 | $491K | 0.28% | Added +273% |
| GRAL GRAIL, Inc. | 3,238 | $339K | 0.19% | New |
| TNXP Tonix Pharmaceuticals Holding Corp. | 74,688 | $190K | 0.11% | Added +17% |
| BMEA Biomea Fusion, Inc. | 33,508 | $20K | <0.1% | Reduced −42% |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| ONC BeOne Medicines AG | 12,273 | $4.9M |
| PCVX Vaxcyte, Inc. | 66,793 | $3.9M |
| ORIC ORIC Pharmaceuticals, Inc. | 406,077 | $3.1M |
| ACRS Aclaris Therapeutics, Inc. | 257,675 | $902K |
| TARA Protara Therapeutics, Inc. | 121,457 | $291K |
| SION Sionna Therapeutics, Inc. | 63,156 | $188K |
| FTH Faeth Therapeutics, Inc. | 14,175 | $123K |